FDA Determines Regulatory Review Period for RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM

Summary

The U.S. Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).